TITLE

Product Summaries

PUB. DATE
August 1999
SOURCE
Worldwide Biotech;Aug99, Vol. 11 Issue 8, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Presents information on the neurology products being marketed by Draxis Health Inc. in Canada. Mechanism of action of Zanaflex; Diastat; Mysoline.
ACCESSION #
2110824

 

Related Articles

  • DRAXIS Acquires Canadian Rights to 8 Elan Neurology Products.  // Worldwide Biotech;Aug99, Vol. 11 Issue 8, p2 

    Reports that Draxis Health Inc. has in-licensed from Elan Corp. PLC the exclusive Canadian rights to eight neurology products. Conditions under the agreement; Task of Draxis Pharmaceutica; Comments from officials of both companies.

  • Current Treatment Approaches for Neoplastic Meningitis: Nursing Management of Patients Receiving Intrathecal DepoCyt{supTM]. Craig, Catherine // Oncology Nursing Forum;Sep2000, Vol. 27 Issue 8, p1225 

    Discusses neoplastic meningitis and the nursing implications for the intrathecal administration of chemotherapy. Signs and symptoms of neoplastic meningitis; Diagnosis; Treatment.

  • Opinion and Evidence in Neurology and Psychiatry.  // CNS Drugs;2003, Vol. 17 Issue 7, p533 

    The management of neurological and psychiatric disorders is a vast and evolving area for researchers, primary care physicians and specialists. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy for neurological and psychiatric disorders, this section of...

  • Benefits and Risks of Pharmacotherapy for Narcolepsy. Mitler, M.M.; Hayduk, R. // Drug Safety;Aug2002, Vol. 25 Issue 11, p791 

    Narcolepsy is a life-long central nervous system (CNS) syndrome characterised by excessive sleepiness, cataplexy, sleep paralysis, hypnagogic hallucinations and disturbed night-time sleep. Unsuccessfully treated narcolepsy confers increased risks on patients and on society due to the patient's...

  • Acute Transient Cerebral Toxicity Associated with Administration of High-Dose Methotrexate. R. Mittal; H. Mottl; J. Nemec // Medical Principles & Practice;May/Jun2005, Vol. 14 Issue 3, p202 

    Objective: To report the first case of transient central nervous system toxicity after administration of high-dose methotrexate (HDMTX) in the Middle East. Clinical Presentation: A 10-year-old boy was diagnosed with osteosarcoma of the proximal end of the left tibia. He underwent primary...

  • Opinion and Evidence in Neurology and Psychiatry.  // CNS Drugs;2003, Vol. 17 Issue 12, p921 

    The management of neurological and psychiatric disorders is a vast and evolving area for researchers, primary care physicians and specialists. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy for neurological and psychiatric disorders, this section of...

  • A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors. Streffer, J.; Schabet, M.; Bamberg, M.; Grote, E. H.; Meyermann, R.; Voigt, K.; Dichgans, J.; Weller, M. // Journal of Neurology;Apr2000, Vol. 247 Issue 4, p297 

    Oligodendroglial tumors have been identified as a subgroup of glial neoplasms with a distinctly better response to chemotherapy and overall survival than purely astrocytic gliomas. Here we report our experience with adjuvant postirradiation and preirradiation chemotherapy using procarbazine,...

  • Treatment of CNS dissemination in systemic lymphoma. M. Chamberlain // Journal of Neuro-Oncology;Aug2007, Vol. 84 Issue 1, p107 

    Summary  The frequency of central nervous system (CNS) dissemination in non-Hodgkin’s lymphoma (NHL) varies and is dependent on NHL histology. More than 50% of patients with CNS involvement have advanced and progressive systemic disease. While CNS involvement at...

  • Multiple sclerosis. David, W. Marvin // Drug Topics;6/19/2000, Vol. 144 Issue 12, p93 

    Provides information on multiple sclerosis (MS), a degenerative disease in the central nervous system. Epidemiology and etiologic theories of MS; Pathophysiology of MS; Details on the pharmacotherapy and primary immunologic therapies for MS.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics